title: Postnatal erythropoietin treatment mitigates neural cell loss after systemic prenatal hypoxic-ischemic injury.
abstract: OBJECTIVE
  Brain injury from preterm birth predisposes children to cerebral palsy, epilepsy, cognitive delay, and behavioral abnormalities. The CNS injury often begins before the early birth, which hinders diagnosis and concurrent treatment. Safe, effective postnatal interventions are urgently needed to minimize these chronic neurological deficits. Erythropoietin (EPO) is a pleiotropic neuroprotective cytokine, but the biological basis of its efficacy in the damaged developing brain remains unclear. Coordinated expression of EPO ligand and receptor expression occurs during CNS development to promote neural cell survival. The authors propose that prenatal third trimester global hypoxia-ischemia disrupts the developmentally regulated expression of neural cell EPO signaling, and predisposes neural cells to death. Furthermore, the authors suggest that neonatal exogenous recombinant human EPO (rhEPO) administration can restore the mismatch of EPO ligand and receptor levels, and enhance neural cell survival.
  
  
  METHODS
  Transient systemic hypoxia-ischemia (TSHI) on embryonic Day 18 in rats mimics human early-third trimester placental insufficiency. This model was used to test the authors' hypothesis using a novel clinically relevant paradigm of prenatal injury on embryonic Day 18, neonatal systemic rhEPO administration initiated 4 days after injury on postnatal Day 1, and histological, biochemical, and functional analyses in neonatal, juvenile, and adult rats.
  
  
  RESULTS
  The results showed that prenatal TSHI upregulates brain EPO receptors, but not EPO ligand. Sustained EPO receptor upregulation was pronounced on oligodendroglial lineage cells and neurons, neural cell populations particularly prone to loss from CNS injury due to preterm birth. Postnatal rhEPO administration after prenatal TSHI minimized histological damage and rescued oligodendrocytes and gamma-aminobutyric acidergic interneurons. Myelin basic protein expression in adult rats after insult was reduced compared with sham controls, but could be restored to near normal levels by neonatal rhEPO treatment. Erythropoietin-treated TSHI rats performed significantly better than their saline-treated peers as adults in motor skills tests, and showed significant seizure threshold restoration using a pentylenetetrazole increasing-dose paradigm.
  
  
  CONCLUSIONS
  These data demonstrate that neonatal rhEPO administration in a novel clinically relevant paradigm initiated 4 days after a global prenatal hypoxic-ischemic insult in rats rescues neural cells, and induces lasting histological and functional improvement in adult rats.
authors.affiliation: Department of Neurosurgery, Rainbow Babies & Children's Hospital, Center for Translational Neuroscience, The Neurological Institute of University Hospitals Case Medical Center, Case Western Reserve School of Medicine, Cleveland, Ohio 44106, USA.
authors.forename: Marcus
authors.initials: M
authors.lastname: Mazur
authors.forename: Robert H
authors.initials: RH
authors.lastname: Miller
authors.forename: Shenandoah
authors.initials: S
authors.lastname: Robinson
mesh_terms: D000818:Animals; D015153:Blotting, Western; D016923:Cell Death / Q000187:drug effects; D004921:Erythropoietin / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use*; D005315:Fetal Diseases / Q000473:pathology* / Q000503:physiopathology; D020925:Hypoxia-Ischemia, Brain / Q000473:pathology* / Q000503:physiopathology; D007150:Immunohistochemistry; D008024:Ligands; D009048:Motor Skills; D009474:Neurons / Q000737:chemistry / Q000187:drug effects* / Q000473:pathology; D009836:Oligodendroglia / Q000737:chemistry; D051381:Rats; D017207:Rats, Sprague-Dawley; D017467:Receptors, Erythropoietin / Q000032:analysis; D011994:Recombinant Proteins; D012640:Seizures / Q000503:physiopathology
chemical_list: D008024:Ligands; D017467:Receptors, Erythropoietin; D011994:Recombinant Proteins; D004921:Erythropoietin
references.citation: Lancet Neurol. 2009 Jan;8(1):110-24
references.pmid: 19081519
references.citation: Neurosci Lett. 2007 Oct 2;425(3):177-82
references.pmid: 17825990
references.citation: Eur J Clin Pharmacol. 2005 May;61(3):189-95
references.pmid: 15776276
references.citation: Physiology (Bethesda). 2008 Oct;23:263-74
references.pmid: 18927202
references.citation: Nat Neurosci. 2007 Apr;10(4):453-61
references.pmid: 17351636
references.citation: Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10659-64
references.pmid: 12130665
references.citation: Neonatology. 2007;91(1):36-43
references.pmid: 17344650
references.citation: Natl Vital Stat Rep. 2007 Dec 5;56(6):1-103
references.pmid: 18277471
references.citation: Pediatr Res. 2007 Jun;61(6):671-5
references.pmid: 17426655
references.citation: Anat Embryol (Berl). 2005 Oct;210(3):209-19
references.pmid: 16151855
references.citation: Brain Res. 2005 May 31;1045(1-2):22-30
references.pmid: 15910759
references.citation: Neuroscience. 2007 Feb 9;144(3):865-77
references.pmid: 17141961
references.citation: Nature. 1996 May 30;381(6581):415-21
references.pmid: 8632796
references.citation: Pediatr Res. 2005 Aug;58(2):297-301
references.pmid: 16055937
references.citation: Life Sci. 2006 Apr 25;78(22):2571-6
references.pmid: 16343549
references.citation: J Neurosci. 2000 Nov 1;20(21):7994-8004
references.pmid: 11050120
references.citation: Neuropediatrics. 1999 Feb;30(1):14-8
references.pmid: 10222455
references.citation: Pediatr Res. 2005 Jul;58(1):106-11
references.pmid: 15879287
references.citation: Brain Dev. 2003 Oct;25(7):494-8
references.pmid: 13129593
references.citation: Epilepsy Behav. 2005 Nov;7(3):345-63
references.pmid: 16061421
references.citation: Pediatrics. 2008 Aug;122(2):383-91
references.pmid: 18676557
references.citation: J Neurosci Methods. 2002 Apr 15;115(2):169-79
references.pmid: 11992668
references.citation: Neurology. 2007 Nov 6;69(19):1816-22
references.pmid: 17984448
references.citation: Epilepsia. 2005 Oct;46(10):1599-602
references.pmid: 16190930
references.citation: Nature. 2001 Aug 9;412(6847):641-7
references.pmid: 11493922
references.citation: Neurobiol Dis. 2005 Apr;18(3):568-81
references.pmid: 15755683
references.citation: Pediatrics. 2005 Jul;116(1):221-5
references.pmid: 15995055
references.citation: Biol Neonate. 2003;83(3):224-8
references.pmid: 12660442
references.citation: J Cereb Blood Flow Metab. 2007 May;27(5):1043-54
references.pmid: 17077815
references.citation: Pediatrics. 2008 Aug;122(2):375-82
references.pmid: 18676556
references.citation: J Biol Chem. 2007 Aug 31;282(35):25875-83
references.pmid: 17604282
references.citation: Nucleic Acids Res. 2001 May 1;29(9):e45
references.pmid: 11328886
references.citation: Neonatology. 2008;94(4):255-66
references.pmid: 18784421
references.citation: Dev Neurosci. 2007;29(4-5):321-30
references.pmid: 17762200
references.citation: Dev Sci. 2006 Jul;9(4):338-49
references.pmid: 16764607
references.citation: Pediatrics. 2005 Apr;115(4):997-1003
references.pmid: 15805376
references.citation: Development. 2002 Jan;129(2):505-16
references.pmid: 11807041
references.citation: J Neurosurg. 2006 Jun;104(6 Suppl):396-408
references.pmid: 16776375
references.citation: Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10526-31
references.pmid: 10984541
references.citation: J Biol Chem. 1997 Dec 19;272(51):32395-400
references.pmid: 9405448
references.citation: Neurobiol Dis. 2006 Nov;24(2):357-66
references.pmid: 16959492
references.citation: Am J Physiol Regul Integr Comp Physiol. 2008 Dec;295(6):R1973-81
references.pmid: 18832080
references.citation: Childs Nerv Syst. 2003 Jan;19(1):19-22
references.pmid: 12541081
references.citation: J Neurosci. 2006 Jan 25;26(4):1269-74
references.pmid: 16436614
references.citation: Acta Neuropathol. 2001 Mar;101(3):271-6
references.pmid: 11307627
references.citation: J Neurosci. 2006 Sep 13;26(37):9471-81
references.pmid: 16971531
references.citation: J Neurotrauma. 2009 Sep;26(9):1557-66
references.pmid: 19203226
references.citation: Anat Embryol (Berl). 2004 Mar;207(6):503-12
references.pmid: 14770308
references.citation: Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9855-60
references.pmid: 15210945
references.citation: Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4044-9
references.pmid: 11259643
references.citation: JAMA. 2005 Jul 20;294(3):318-25
references.pmid: 16030276
references.citation: Pediatr Res. 1999 Nov;46(5):543-7
references.pmid: 10541316
references.citation: Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):6185-90
references.pmid: 18413601
references.citation: J Neuropathol Exp Neurol. 2002 Feb;61(2):197-211
references.pmid: 11853021
references.citation: Int J Dev Neurosci. 2008 Feb;26(1):103-11
references.pmid: 17936539
references.citation: Behav Brain Res. 2004 Aug 12;153(1):77-86
references.pmid: 15219709
references.citation: Neurosci Lett. 2004 Jan 30;355(3):165-8
references.pmid: 14732457
references.citation: BJOG. 2005 Mar;112 Suppl 1:10-5
references.pmid: 15715587
references.citation: Eur J Neurol. 2008 Feb;15(2):140-9
references.pmid: 18093155
references.citation: Pediatr Res. 2005 Jun;57(6):865-72
references.pmid: 15774844
references.citation: J Cereb Blood Flow Metab. 1999 Jun;19(6):643-51
references.pmid: 10366194